Quirke, Philip

Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Argilés, G., Tabernero, J., Labianca, R., Hochhauser, D., Salazar, R., Iveson, T., Laurent-Puig, P., Quirke, P., Yoshino, T., Taieb, J., et al. (2020) · Annals of Oncology

Colorectal Cancer Surgical TreatmentsColorectal Cancer Treatments and Studies

Cited by 1,375

Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies

Venderbosch, S., Nagtegaal, I. D., Maughan, T. S., Smith, C. G., Cheadle, J. P., Fisher, D., Kaplan, R., Quirke, P., Seymour, M. T., Richman, S. D., et al. (2014) · Clinical Cancer Research

Colorectal Cancer Treatments and StudiesGenetic factors in colorectal cancer

Cited by 772

KRAS and BRAF Mutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial

Richman, S. D., Seymour, M. T., Chambers, P., Elliott, F., Daly, C. L., Meade, A. M., Taylor, G., Barrett, J. H., & Quirke, P. (2009) · Journal of Clinical Oncology

Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments

Cited by 560

European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full Supplement publication

von Karsa, L., Patnick, J., Segnan, N., Atkin, W. S., Halloran, S., Lansdorp-Vogelaar, I., Malila, N., Minozzi, S., Moss, S., Quirke, P., et al. (2012) · Endoscopy

Colorectal Cancer Screening and DetectionColorectal Cancer Surgical Treatments

Cited by 533

Clinical-Grade Detection of Microsatellite Instability in Colorectal Tumors by Deep Learning

Echle, A., Grabsch, H. I., Quirke, P., van den Brandt, P. A., West, N. P., Hutchins, G. G. A., Heij, L. R., Tan, X., Richman, S. D., Krause, J., et al. (2020) · Gastroenterology

Genetic factors in colorectal cancerAI in cancer detection

Cited by 376

Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study

Wagner, S. J., Reisenbüchler, D., West, N. P., Niehues, J. M., Zhu, J., Foersch, S., Veldhuizen, G. P., Quirke, P., Grabsch, H. I., van den Brandt, P. A., et al. (2023) · Cancer Cell

AI in cancer detectionRadiomics and Machine Learning in Medical Imaging

Cited by 275

HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR , FOCUS and PICCOLO colorectal cancer trials

Richman, S. D., Southward, K., Chambers, P., Cross, D., Barrett, J., Hemmings, G., Taylor, M., Wood, H., Hutchins, G., Foster, J. M., et al. (2016) · The Journal of Pathology

Colorectal Cancer Treatments and StudiesHER2/EGFR in Cancer Research

Cited by 241

Swarm learning for decentralized artificial intelligence in cancer histopathology

Saldanha, O. L., Quirke, P., West, N. P., James, J. A., Loughrey, M. B., Grabsch, H. I., Salto-Tellez, M., Alwers, E., Cifci, D., Ghaffari Laleh, N., et al. (2022) · Nature Medicine

AI in cancer detectionArtificial Intelligence in Healthcare and Education

Cited by 227

Development and validation of deep learning classifiers to detect Epstein-Barr virus and microsatellite instability status in gastric cancer: a retrospective multicentre cohort study

Muti, H. S., Heij, L. R., Keller, G., Kohlruss, M., Langer, R., Dislich, B., Cheong, J.-H., Kim, Y.-W., Kim, H., Kook, M.-C., et al. (2021) · The Lancet Digital Health

AI in cancer detectionGastric Cancer Management and Outcomes

Cited by 126

Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients With RAS Wild-Type Advanced Colorectal Cancer

Seligmann, J. F., Elliott, F., Richman, S. D., Jacobs, B., Hemmings, G., Brown, S., Barrett, J. H., Tejpar, S., Quirke, P., & Seymour, M. T. (2016) · JAMA Oncology

Colorectal Cancer Treatments and StudiesHER2/EGFR in Cancer Research

Cited by 113

Artificial intelligence for detection of microsatellite instability in colorectal cancer—a multicentric analysis of a pre-screening tool for clinical application

Echle, A., Ghaffari Laleh, N., Quirke, P., Grabsch, H. I., Muti, H. S., Saldanha, O. L., Brockmoeller, S. F., van den Brandt, P. A., Hutchins, G. G. A., Richman, S. D., et al. (2022) · ESMO Open

AI in cancer detectionGenetic factors in colorectal cancer

Cited by 111

End-to-end prognostication in colorectal cancer by deep learning: a retrospective, multicentre study

Jiang, X., Hoffmeister, M., Brenner, H., Muti, H. S., Yuan, T., Foersch, S., West, N. P., Brobeil, A., Jonnagaddala, J., Hawkins, N., et al. (2024) · The Lancet Digital Health

AI in cancer detectionRadiomics and Machine Learning in Medical Imaging

Cited by 108

Intra-tumoral Heterogeneity of KRAS and BRAF Mutation Status in Patients with Advanced Colorectal Cancer (aCRC) and Cost-Effectiveness of Multiple Sample Testing

Richman, S. D., Chambers, P., Seymour, M. T., Daly, C., Grant, S., Hemmings, G., & Quirke, P. (2011) · Analytical Cellular Pathology

Colorectal Cancer Treatments and StudiesCancer Genomics and Diagnostics

Cited by 70

Association of Tumor HER3 Messenger RNA Expression With Panitumumab Efficacy in Advanced Colorectal Cancer

Seligmann, J. F., Hatch, A. J., Richman, S. D., Elliott, F., Jacobs, B., Brown, S., Hurwitz, H., Barrett, J. H., Quirke, P., Nixon, A. B., et al. (2018) · JAMA Oncology

Colorectal Cancer Treatments and StudiesHER2/EGFR in Cancer Research

Cited by 25

Lynch syndrome screening in colorectal cancer: results of a prospective 2‐year regional programme validating the NICE diagnostics guidance pathway throughout a 5.2‐million population

West, N. P., Gallop, N., Kaye, D., Glover, A., Young, C., Hutchins, G. G. A., Brockmoeller, S. F., Westwood, A. C., Rossington, H., Quirke, P., et al. (2021) · Histopathology

Genetic factors in colorectal cancerBRCA gene mutations in cancer

Cited by 15